Respiratory Tract Infections  >>  Alvesco (ciclesonide)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT01371786: A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler

Completed
1
14
Europe
ciclesonide nasal aerosol, mometasone Aqueous (AQ) nasal spray
Sunovion
Allergic Rhinitis (AR)
08/11
08/11

Download Options